Inflation Reduction Act (IRA) Revised Program Guidance
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Issuing agencies
Abstract
The Centers for Medicare & Medicaid Services (CMS) is announcing the availability of CMS' revised guidance for the Medicare Drug Price Negotiation Program for the implementation of the Inflation Reduction Act. CMS will be releasing additional Inflation Reduction Act-related guidance; all can be viewed on the dedicated Inflation Reduction Act section of the CMS website.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 126 (Monday, July 3, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 126 (Monday, July 3, 2023)]
[Notices]
[Page 42723]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-14097]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[CMS-1800-N]
Inflation Reduction Act (IRA) Revised Program Guidance
AGENCY: Centers for Medicare & Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Medicare & Medicaid Services (CMS) is
announcing the availability of CMS' revised guidance for the Medicare
Drug Price Negotiation Program for the implementation of the Inflation
Reduction Act. CMS will be releasing additional Inflation Reduction
Act-related guidance; all can be viewed on the dedicated Inflation
Reduction Act section of the CMS website.
ADDRESSES: Inquiries related to the revised guidance should be sent to
<a href="/cdn-cgi/l/email-protection#e0a9b2a1b28582819485818e84ae85878f94898194898f8ea0838d93ce888893ce878f96"><span class="__cf_email__" data-cfemail="19504b584b7c7b786d7c78777d577c7e766d70786d707677597a746a3771716a377e766f">[email protected]</span></a> with the relevant subject line,
``Medicare Drug Price Negotiation Program Guidance.''
SUPPLEMENTARY INFORMATION: The Inflation Reduction Act was signed into
law on August 16, 2022. Sections 11001 and 11002 of the Inflation
Reduction Act (IRA) (Pub. L. 117-169), signed into law on August 16,
2022, established the Medicare Drug Price Negotiation Program
(hereafter the ``Negotiation Program'') to negotiate Maximum Fair
Prices (MFPs) for certain high expenditure, single source drugs and
biological products. The requirements for this program are described in
sections 1191 through 1198 of the Social Security Act (hereafter ``the
Act'') as added by sections 11001 and 11002 of the Inflation Reduction
Act.
To obtain copies of the revised guidance and the responses to
comments from the initial guidance, as well as other Inflation
Reduction Act-related documents, please access the CMS Inflation
Reduction Act website by copying and pasting the following web address
into your web browser: <a href="https://www.cms.gov/inflation-reduction-act-and-medicare">https://www.cms.gov/inflation-reduction-act-and-medicare</a>. If interested in receiving CMS Inflation Reduction Act
updates by email, individuals may sign up for CMS Inflation Reduction
Act's email updates at <a href="https://www.cms.gov/About-CMS/Agency-Information/Aboutwebsite/EmailUpdates">https://www.cms.gov/About-CMS/Agency-Information/Aboutwebsite/EmailUpdates</a>.
The Administrator of the Centers for Medicare & Medicaid Services
(CMS), Chiquita Brooks-LaSure, having reviewed and approved this
document, authorizes Evell J. Barco Holland, who is the Federal
Register Liaison, to electronically sign this document for purposes of
publication in the Federal Register.
Dated: June 28, 2023.
Evell J. Barco Holland,
Federal Register Liaison, Centers for Medicare & Medicaid Services.
[FR Doc. 2023-14097 Filed 6-30-23; 8:45 am]
BILLING CODE 4120-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.